Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins

Monoclonal antibodies (Mabs) against the Urbani strain of the SARS-associated coronavirus (SARS-CoV) were developed and characterized for reactivity to SARS-CoV and SARS-CoV S, N, M, and E proteins using enzyme-linked immunoabsorbent (ELISA), radioimmunoprecipitation, immunofluorescence, Western Blo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virological methods 2005-09, Vol.128 (1), p.21-28
Hauptverfasser: Tripp, Ralph A., Haynes, Lia M., Moore, Deborah, Anderson, Barbara, Tamin, Azaibi, Harcourt, Brian H., Jones, Les P., Yilla, Mamadi, Babcock, Gregory J., Greenough, Thomas, Ambrosino, Donna M., Alvarez, Rene, Callaway, Justin, Cavitt, Sheana, Kamrud, Kurt, Alterson, Harold, Smith, Jonathan, Harcourt, Jennifer L., Miao, Congrong, Razdan, Raj, Comer, James A., Rollin, Pierre E., Ksiazek, Thomas G., Sanchez, Anthony, Rota, Paul A., Bellini, William J., Anderson, Larry J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 28
container_issue 1
container_start_page 21
container_title Journal of virological methods
container_volume 128
creator Tripp, Ralph A.
Haynes, Lia M.
Moore, Deborah
Anderson, Barbara
Tamin, Azaibi
Harcourt, Brian H.
Jones, Les P.
Yilla, Mamadi
Babcock, Gregory J.
Greenough, Thomas
Ambrosino, Donna M.
Alvarez, Rene
Callaway, Justin
Cavitt, Sheana
Kamrud, Kurt
Alterson, Harold
Smith, Jonathan
Harcourt, Jennifer L.
Miao, Congrong
Razdan, Raj
Comer, James A.
Rollin, Pierre E.
Ksiazek, Thomas G.
Sanchez, Anthony
Rota, Paul A.
Bellini, William J.
Anderson, Larry J.
description Monoclonal antibodies (Mabs) against the Urbani strain of the SARS-associated coronavirus (SARS-CoV) were developed and characterized for reactivity to SARS-CoV and SARS-CoV S, N, M, and E proteins using enzyme-linked immunoabsorbent (ELISA), radioimmunoprecipitation, immunofluorescence, Western Blot and microneutralization assays. Twenty-six mAbs were reactive to SARS-CoV by ELISA, and nine were chosen for detailed characterization. Five mAbs reacted against the S protein, two against the M protein, and one each against the N and E proteins. Two of five S protein mAbs neutralized SARS-CoV infection of Vero E6 cells and reacted to an epitope within amino acids 490–510 in the S protein. While two of the three non-neutralizing antibodies recognized at second epitope within amino acids 270–350. The mAbs characterized should prove useful for developing SARS-CoV diagnostic assays and for studying the biology of infection and pathogenesis of disease.
doi_str_mv 10.1016/j.jviromet.2005.03.021
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7112802</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166093405001084</els_id><sourcerecordid>17651148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-1865ca800e27661cc843f4e29dc67baa110fec071cdb738262a23e07873958563</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhiMEokvhFSpfQCA1YRwnttMDoloVqNSCRIGr5XUmxausvdjOSvAivC7u7kLLqSdbmm_--Wf-ojiiUFGg_PWyWm5s8CtMVQ3QVsAqqOmDYkal6EroZPOwmGWQ5z9rDoonMS4hg4Kxx8UBbaVsJa1nxe9L77wZvdMj0S7Zhe8tRpI8uTr9fFXqGL2xOmFPjA-ZykOnSF5ui3P_7dUJOe8x9w3W6GS9I34gDqcU9Gh_WXedRfu7wgG1SXaD2wnH5OMxudwiZyQrZw_r4BNaF58WjwY9Rny2fw-Lr-_Ovsw_lBef3p_PTy9K0zJIJZW8NVoCYC04p8bIhg0N1l1vuFhoTSkMaEBQ0y8EkzWvdc0QhBSsa2XL2WHxZqe7nhYr7E3eJdtQ62BXOvxUXlv1f8XZ7-rab5SgtJZQZ4EXe4Hgf0wYk1rZaHActUM_RcUlNG0D4l6QCt5S2sgM8h1ogo8x4PDPDQV1E75aqr_hq5vwFTCVw8-NR3d3uW3bp52B53tAR6PHIWhnbLzleCdBMsjc2x2H-fIbi0FFY9EZ7G1Ak1Tv7X1e_gBOfNKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17651148</pqid></control><display><type>article</type><title>Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tripp, Ralph A. ; Haynes, Lia M. ; Moore, Deborah ; Anderson, Barbara ; Tamin, Azaibi ; Harcourt, Brian H. ; Jones, Les P. ; Yilla, Mamadi ; Babcock, Gregory J. ; Greenough, Thomas ; Ambrosino, Donna M. ; Alvarez, Rene ; Callaway, Justin ; Cavitt, Sheana ; Kamrud, Kurt ; Alterson, Harold ; Smith, Jonathan ; Harcourt, Jennifer L. ; Miao, Congrong ; Razdan, Raj ; Comer, James A. ; Rollin, Pierre E. ; Ksiazek, Thomas G. ; Sanchez, Anthony ; Rota, Paul A. ; Bellini, William J. ; Anderson, Larry J.</creator><creatorcontrib>Tripp, Ralph A. ; Haynes, Lia M. ; Moore, Deborah ; Anderson, Barbara ; Tamin, Azaibi ; Harcourt, Brian H. ; Jones, Les P. ; Yilla, Mamadi ; Babcock, Gregory J. ; Greenough, Thomas ; Ambrosino, Donna M. ; Alvarez, Rene ; Callaway, Justin ; Cavitt, Sheana ; Kamrud, Kurt ; Alterson, Harold ; Smith, Jonathan ; Harcourt, Jennifer L. ; Miao, Congrong ; Razdan, Raj ; Comer, James A. ; Rollin, Pierre E. ; Ksiazek, Thomas G. ; Sanchez, Anthony ; Rota, Paul A. ; Bellini, William J. ; Anderson, Larry J.</creatorcontrib><description>Monoclonal antibodies (Mabs) against the Urbani strain of the SARS-associated coronavirus (SARS-CoV) were developed and characterized for reactivity to SARS-CoV and SARS-CoV S, N, M, and E proteins using enzyme-linked immunoabsorbent (ELISA), radioimmunoprecipitation, immunofluorescence, Western Blot and microneutralization assays. Twenty-six mAbs were reactive to SARS-CoV by ELISA, and nine were chosen for detailed characterization. Five mAbs reacted against the S protein, two against the M protein, and one each against the N and E proteins. Two of five S protein mAbs neutralized SARS-CoV infection of Vero E6 cells and reacted to an epitope within amino acids 490–510 in the S protein. While two of the three non-neutralizing antibodies recognized at second epitope within amino acids 270–350. The mAbs characterized should prove useful for developing SARS-CoV diagnostic assays and for studying the biology of infection and pathogenesis of disease.</description><identifier>ISSN: 0166-0934</identifier><identifier>EISSN: 1879-0984</identifier><identifier>DOI: 10.1016/j.jviromet.2005.03.021</identifier><identifier>PMID: 15885812</identifier><identifier>CODEN: JVMEDH</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Animals ; Antibodies, Monoclonal - biosynthesis ; Antibodies, Monoclonal - immunology ; Antibodies, Viral - biosynthesis ; Antibodies, Viral - immunology ; Antibody Specificity ; Biological and medical sciences ; Cell Line ; Chlorocebus aethiops ; Epitope ; Epitope Mapping ; Fundamental and applied biological sciences. Psychology ; Humans ; Immunoassay ; Membrane Glycoproteins - immunology ; Microbiology ; Monoclonal antibody ; Neutralization Tests ; Neutralizing ; Nucleocapsid Proteins - immunology ; SARS Virus - immunology ; SARS-coronavirus ; Severe Acute Respiratory Syndrome - virology ; Spike Glycoprotein, Coronavirus ; Techniques used in virology ; Vero Cells ; Viral Envelope Proteins - immunology ; Viral Matrix Proteins - immunology ; Viral Structural Proteins - immunology ; Virology</subject><ispartof>Journal of virological methods, 2005-09, Vol.128 (1), p.21-28</ispartof><rights>2005 Elsevier B.V.</rights><rights>2005 INIST-CNRS</rights><rights>Copyright © 2005 Elsevier B.V. All rights reserved. 2005 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-1865ca800e27661cc843f4e29dc67baa110fec071cdb738262a23e07873958563</citedby><cites>FETCH-LOGICAL-c530t-1865ca800e27661cc843f4e29dc67baa110fec071cdb738262a23e07873958563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0166093405001084$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16980830$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15885812$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tripp, Ralph A.</creatorcontrib><creatorcontrib>Haynes, Lia M.</creatorcontrib><creatorcontrib>Moore, Deborah</creatorcontrib><creatorcontrib>Anderson, Barbara</creatorcontrib><creatorcontrib>Tamin, Azaibi</creatorcontrib><creatorcontrib>Harcourt, Brian H.</creatorcontrib><creatorcontrib>Jones, Les P.</creatorcontrib><creatorcontrib>Yilla, Mamadi</creatorcontrib><creatorcontrib>Babcock, Gregory J.</creatorcontrib><creatorcontrib>Greenough, Thomas</creatorcontrib><creatorcontrib>Ambrosino, Donna M.</creatorcontrib><creatorcontrib>Alvarez, Rene</creatorcontrib><creatorcontrib>Callaway, Justin</creatorcontrib><creatorcontrib>Cavitt, Sheana</creatorcontrib><creatorcontrib>Kamrud, Kurt</creatorcontrib><creatorcontrib>Alterson, Harold</creatorcontrib><creatorcontrib>Smith, Jonathan</creatorcontrib><creatorcontrib>Harcourt, Jennifer L.</creatorcontrib><creatorcontrib>Miao, Congrong</creatorcontrib><creatorcontrib>Razdan, Raj</creatorcontrib><creatorcontrib>Comer, James A.</creatorcontrib><creatorcontrib>Rollin, Pierre E.</creatorcontrib><creatorcontrib>Ksiazek, Thomas G.</creatorcontrib><creatorcontrib>Sanchez, Anthony</creatorcontrib><creatorcontrib>Rota, Paul A.</creatorcontrib><creatorcontrib>Bellini, William J.</creatorcontrib><creatorcontrib>Anderson, Larry J.</creatorcontrib><title>Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins</title><title>Journal of virological methods</title><addtitle>J Virol Methods</addtitle><description>Monoclonal antibodies (Mabs) against the Urbani strain of the SARS-associated coronavirus (SARS-CoV) were developed and characterized for reactivity to SARS-CoV and SARS-CoV S, N, M, and E proteins using enzyme-linked immunoabsorbent (ELISA), radioimmunoprecipitation, immunofluorescence, Western Blot and microneutralization assays. Twenty-six mAbs were reactive to SARS-CoV by ELISA, and nine were chosen for detailed characterization. Five mAbs reacted against the S protein, two against the M protein, and one each against the N and E proteins. Two of five S protein mAbs neutralized SARS-CoV infection of Vero E6 cells and reacted to an epitope within amino acids 490–510 in the S protein. While two of the three non-neutralizing antibodies recognized at second epitope within amino acids 270–350. The mAbs characterized should prove useful for developing SARS-CoV diagnostic assays and for studying the biology of infection and pathogenesis of disease.</description><subject>Animals</subject><subject>Antibodies, Monoclonal - biosynthesis</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibodies, Viral - biosynthesis</subject><subject>Antibodies, Viral - immunology</subject><subject>Antibody Specificity</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Chlorocebus aethiops</subject><subject>Epitope</subject><subject>Epitope Mapping</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Microbiology</subject><subject>Monoclonal antibody</subject><subject>Neutralization Tests</subject><subject>Neutralizing</subject><subject>Nucleocapsid Proteins - immunology</subject><subject>SARS Virus - immunology</subject><subject>SARS-coronavirus</subject><subject>Severe Acute Respiratory Syndrome - virology</subject><subject>Spike Glycoprotein, Coronavirus</subject><subject>Techniques used in virology</subject><subject>Vero Cells</subject><subject>Viral Envelope Proteins - immunology</subject><subject>Viral Matrix Proteins - immunology</subject><subject>Viral Structural Proteins - immunology</subject><subject>Virology</subject><issn>0166-0934</issn><issn>1879-0984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhiMEokvhFSpfQCA1YRwnttMDoloVqNSCRIGr5XUmxausvdjOSvAivC7u7kLLqSdbmm_--Wf-ojiiUFGg_PWyWm5s8CtMVQ3QVsAqqOmDYkal6EroZPOwmGWQ5z9rDoonMS4hg4Kxx8UBbaVsJa1nxe9L77wZvdMj0S7Zhe8tRpI8uTr9fFXqGL2xOmFPjA-ZykOnSF5ui3P_7dUJOe8x9w3W6GS9I34gDqcU9Gh_WXedRfu7wgG1SXaD2wnH5OMxudwiZyQrZw_r4BNaF58WjwY9Rny2fw-Lr-_Ovsw_lBef3p_PTy9K0zJIJZW8NVoCYC04p8bIhg0N1l1vuFhoTSkMaEBQ0y8EkzWvdc0QhBSsa2XL2WHxZqe7nhYr7E3eJdtQ62BXOvxUXlv1f8XZ7-rab5SgtJZQZ4EXe4Hgf0wYk1rZaHActUM_RcUlNG0D4l6QCt5S2sgM8h1ogo8x4PDPDQV1E75aqr_hq5vwFTCVw8-NR3d3uW3bp52B53tAR6PHIWhnbLzleCdBMsjc2x2H-fIbi0FFY9EZ7G1Ak1Tv7X1e_gBOfNKg</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Tripp, Ralph A.</creator><creator>Haynes, Lia M.</creator><creator>Moore, Deborah</creator><creator>Anderson, Barbara</creator><creator>Tamin, Azaibi</creator><creator>Harcourt, Brian H.</creator><creator>Jones, Les P.</creator><creator>Yilla, Mamadi</creator><creator>Babcock, Gregory J.</creator><creator>Greenough, Thomas</creator><creator>Ambrosino, Donna M.</creator><creator>Alvarez, Rene</creator><creator>Callaway, Justin</creator><creator>Cavitt, Sheana</creator><creator>Kamrud, Kurt</creator><creator>Alterson, Harold</creator><creator>Smith, Jonathan</creator><creator>Harcourt, Jennifer L.</creator><creator>Miao, Congrong</creator><creator>Razdan, Raj</creator><creator>Comer, James A.</creator><creator>Rollin, Pierre E.</creator><creator>Ksiazek, Thomas G.</creator><creator>Sanchez, Anthony</creator><creator>Rota, Paul A.</creator><creator>Bellini, William J.</creator><creator>Anderson, Larry J.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20050901</creationdate><title>Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins</title><author>Tripp, Ralph A. ; Haynes, Lia M. ; Moore, Deborah ; Anderson, Barbara ; Tamin, Azaibi ; Harcourt, Brian H. ; Jones, Les P. ; Yilla, Mamadi ; Babcock, Gregory J. ; Greenough, Thomas ; Ambrosino, Donna M. ; Alvarez, Rene ; Callaway, Justin ; Cavitt, Sheana ; Kamrud, Kurt ; Alterson, Harold ; Smith, Jonathan ; Harcourt, Jennifer L. ; Miao, Congrong ; Razdan, Raj ; Comer, James A. ; Rollin, Pierre E. ; Ksiazek, Thomas G. ; Sanchez, Anthony ; Rota, Paul A. ; Bellini, William J. ; Anderson, Larry J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-1865ca800e27661cc843f4e29dc67baa110fec071cdb738262a23e07873958563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - biosynthesis</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibodies, Viral - biosynthesis</topic><topic>Antibodies, Viral - immunology</topic><topic>Antibody Specificity</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Chlorocebus aethiops</topic><topic>Epitope</topic><topic>Epitope Mapping</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Microbiology</topic><topic>Monoclonal antibody</topic><topic>Neutralization Tests</topic><topic>Neutralizing</topic><topic>Nucleocapsid Proteins - immunology</topic><topic>SARS Virus - immunology</topic><topic>SARS-coronavirus</topic><topic>Severe Acute Respiratory Syndrome - virology</topic><topic>Spike Glycoprotein, Coronavirus</topic><topic>Techniques used in virology</topic><topic>Vero Cells</topic><topic>Viral Envelope Proteins - immunology</topic><topic>Viral Matrix Proteins - immunology</topic><topic>Viral Structural Proteins - immunology</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tripp, Ralph A.</creatorcontrib><creatorcontrib>Haynes, Lia M.</creatorcontrib><creatorcontrib>Moore, Deborah</creatorcontrib><creatorcontrib>Anderson, Barbara</creatorcontrib><creatorcontrib>Tamin, Azaibi</creatorcontrib><creatorcontrib>Harcourt, Brian H.</creatorcontrib><creatorcontrib>Jones, Les P.</creatorcontrib><creatorcontrib>Yilla, Mamadi</creatorcontrib><creatorcontrib>Babcock, Gregory J.</creatorcontrib><creatorcontrib>Greenough, Thomas</creatorcontrib><creatorcontrib>Ambrosino, Donna M.</creatorcontrib><creatorcontrib>Alvarez, Rene</creatorcontrib><creatorcontrib>Callaway, Justin</creatorcontrib><creatorcontrib>Cavitt, Sheana</creatorcontrib><creatorcontrib>Kamrud, Kurt</creatorcontrib><creatorcontrib>Alterson, Harold</creatorcontrib><creatorcontrib>Smith, Jonathan</creatorcontrib><creatorcontrib>Harcourt, Jennifer L.</creatorcontrib><creatorcontrib>Miao, Congrong</creatorcontrib><creatorcontrib>Razdan, Raj</creatorcontrib><creatorcontrib>Comer, James A.</creatorcontrib><creatorcontrib>Rollin, Pierre E.</creatorcontrib><creatorcontrib>Ksiazek, Thomas G.</creatorcontrib><creatorcontrib>Sanchez, Anthony</creatorcontrib><creatorcontrib>Rota, Paul A.</creatorcontrib><creatorcontrib>Bellini, William J.</creatorcontrib><creatorcontrib>Anderson, Larry J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tripp, Ralph A.</au><au>Haynes, Lia M.</au><au>Moore, Deborah</au><au>Anderson, Barbara</au><au>Tamin, Azaibi</au><au>Harcourt, Brian H.</au><au>Jones, Les P.</au><au>Yilla, Mamadi</au><au>Babcock, Gregory J.</au><au>Greenough, Thomas</au><au>Ambrosino, Donna M.</au><au>Alvarez, Rene</au><au>Callaway, Justin</au><au>Cavitt, Sheana</au><au>Kamrud, Kurt</au><au>Alterson, Harold</au><au>Smith, Jonathan</au><au>Harcourt, Jennifer L.</au><au>Miao, Congrong</au><au>Razdan, Raj</au><au>Comer, James A.</au><au>Rollin, Pierre E.</au><au>Ksiazek, Thomas G.</au><au>Sanchez, Anthony</au><au>Rota, Paul A.</au><au>Bellini, William J.</au><au>Anderson, Larry J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins</atitle><jtitle>Journal of virological methods</jtitle><addtitle>J Virol Methods</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>128</volume><issue>1</issue><spage>21</spage><epage>28</epage><pages>21-28</pages><issn>0166-0934</issn><eissn>1879-0984</eissn><coden>JVMEDH</coden><abstract>Monoclonal antibodies (Mabs) against the Urbani strain of the SARS-associated coronavirus (SARS-CoV) were developed and characterized for reactivity to SARS-CoV and SARS-CoV S, N, M, and E proteins using enzyme-linked immunoabsorbent (ELISA), radioimmunoprecipitation, immunofluorescence, Western Blot and microneutralization assays. Twenty-six mAbs were reactive to SARS-CoV by ELISA, and nine were chosen for detailed characterization. Five mAbs reacted against the S protein, two against the M protein, and one each against the N and E proteins. Two of five S protein mAbs neutralized SARS-CoV infection of Vero E6 cells and reacted to an epitope within amino acids 490–510 in the S protein. While two of the three non-neutralizing antibodies recognized at second epitope within amino acids 270–350. The mAbs characterized should prove useful for developing SARS-CoV diagnostic assays and for studying the biology of infection and pathogenesis of disease.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>15885812</pmid><doi>10.1016/j.jviromet.2005.03.021</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0166-0934
ispartof Journal of virological methods, 2005-09, Vol.128 (1), p.21-28
issn 0166-0934
1879-0984
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7112802
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antibodies, Monoclonal - biosynthesis
Antibodies, Monoclonal - immunology
Antibodies, Viral - biosynthesis
Antibodies, Viral - immunology
Antibody Specificity
Biological and medical sciences
Cell Line
Chlorocebus aethiops
Epitope
Epitope Mapping
Fundamental and applied biological sciences. Psychology
Humans
Immunoassay
Membrane Glycoproteins - immunology
Microbiology
Monoclonal antibody
Neutralization Tests
Neutralizing
Nucleocapsid Proteins - immunology
SARS Virus - immunology
SARS-coronavirus
Severe Acute Respiratory Syndrome - virology
Spike Glycoprotein, Coronavirus
Techniques used in virology
Vero Cells
Viral Envelope Proteins - immunology
Viral Matrix Proteins - immunology
Viral Structural Proteins - immunology
Virology
title Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T23%3A45%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Monoclonal%20antibodies%20to%20SARS-associated%20coronavirus%20(SARS-CoV):%20Identification%20of%20neutralizing%20and%20antibodies%20reactive%20to%20S,%20N,%20M%20and%20E%20viral%20proteins&rft.jtitle=Journal%20of%20virological%20methods&rft.au=Tripp,%20Ralph%20A.&rft.date=2005-09-01&rft.volume=128&rft.issue=1&rft.spage=21&rft.epage=28&rft.pages=21-28&rft.issn=0166-0934&rft.eissn=1879-0984&rft.coden=JVMEDH&rft_id=info:doi/10.1016/j.jviromet.2005.03.021&rft_dat=%3Cproquest_pubme%3E17651148%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17651148&rft_id=info:pmid/15885812&rft_els_id=S0166093405001084&rfr_iscdi=true